Annual report pursuant to Section 13 and 15(d)

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail)

v3.3.1.900
Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]      
Receipt of common units due to common unit adjustment $ (15,421) $ (8,216) $ (98,797)
Equity in income of affiliates (28,126) (22,743) (22,682)
Equity in other comprehensive income 3,119 (676) (2,386)
Ending Balance (18,140) (18,541) (20,701)
Other Comprehensive Loss      
Schedule of Equity Method Investments [Line Items]      
Ending Balance 2,735 (896) (1,838)
Cash Received      
Schedule of Equity Method Investments [Line Items]      
Receipt of excess cash distributions 29,468 27,352 32,540
Receipt under tax receivable agreement 5,052 6,357 1,819
Revenues earned under ESA [1] 11,330 9,249 7,960
Ending Balance 45,850 42,958 42,319
Other Revenue      
Schedule of Equity Method Investments [Line Items]      
Revenues earned under ESA [1] (11,330) (9,249) (7,960)
Ending Balance (19,836) (16,675) (13,633)
Equity in Earnings      
Schedule of Equity Method Investments [Line Items]      
Ending Balance (8,510) (6,142) (11,578)
Distributions from NCM      
Schedule of Equity Method Investments [Line Items]      
Receipt of excess cash distributions (15,396) (14,778) (19,374)
Receipt under tax receivable agreement (2,744) (3,763) (1,327)
Ending Balance (18,140) (18,541) (20,701)
Investment In NCM      
Schedule of Equity Method Investments [Line Items]      
Beginning Balance 178,939 178,853 78,123
Receipt of common units due to annual common unit adjustment 15,421 8,216 8,869
Receipt of excess cash distributions (14,072) (12,574) (13,166)
Receipt under tax receivable agreement (2,308) (2,594) (492)
Equity in income of affiliates 8,510 6,142 13,753 [2]
Equity in other comprehensive income (2,735) 896 1,838
Ending Balance 183,755 178,939 178,853
Investment In NCM | Extraordinary Common Unit Adjustment      
Schedule of Equity Method Investments [Line Items]      
Receipt of common units due to common unit adjustment     89,928
Deferred Revenue      
Schedule of Equity Method Investments [Line Items]      
Receipt of common units due to annual common unit adjustment (15,421) (8,216) (8,869)
Beginning Balance (335,219) (334,429) (241,305)
Ending Balance (342,134) (335,219) (334,429)
Deferred Revenue | Extraordinary Common Unit Adjustment      
Schedule of Equity Method Investments [Line Items]      
Receipt of common units due to common unit adjustment     (89,928)
NCM      
Schedule of Equity Method Investments [Line Items]      
Beginning Balance 178,939    
Ending Balance 183,755 178,939  
Beginning Balance (335,219)    
Ending Balance (342,134) (335,219)  
NCM | Other Comprehensive Loss      
Schedule of Equity Method Investments [Line Items]      
Equity in other comprehensive income 2,735 (896) (1,838)
NCM | Other Revenue      
Schedule of Equity Method Investments [Line Items]      
Amortization of deferred revenue (8,506) (7,426) (5,673)
NCM | Equity in Earnings      
Schedule of Equity Method Investments [Line Items]      
Equity in income of affiliates (8,510) (6,142) (11,578) [2]
NCM | Deferred Revenue      
Schedule of Equity Method Investments [Line Items]      
Amortization of deferred revenue $ 8,506 $ 7,426 $ 5,673
[1] Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire were approximately $11,958, $11,489 and $9,819 for the years ended December 31, 2013, 2014 and 2015, respectively.
[2] A portion of the equity in earnings recorded for the year ended December 31, 2013 was recorded as a reduction in our investment basis in a joint venture (AC JV, LLC) that the Company, along with Regal and AMC, recently formed with NCM. See Note 7.